125 filings
Page 2 of 7
8-K
krx8a1g25tszu
29 Nov 23
Entry into a Material Definitive Agreement
8:10am
8-K
t38wib85 lcc
28 Nov 23
180 Life Sciences Announces Review of Strategic Alternatives
9:00am
8-K
neljf7 171qd1
16 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
yvwvs cp86bqr
18 Oct 23
Other Events
4:33pm
8-K
u6dknmiy2sl
13 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
k14q29i5hf ahq0b
28 Sep 23
Termination of a Material Definitive Agreement
4:18pm
8-K
fjgn6wu
22 Sep 23
Other Events
9:00am
8-K
g42wkmr cd0akzkjd
8 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
2dc4yg738wgvv
7 Sep 23
Material Modifications to Rights of Security Holders
8:30am
8-K
kvk88tow2b7bm79
15 Aug 23
180 Life Sciences Corp. Announces Pricing of $3 Million Public Offering
4:31pm
8-K
2w90i4d3w xwlhikl
7 Aug 23
180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake
9:00am
8-K
ceq8inw64ym
3 Aug 23
Regulation FD Disclosure
8:00am
8-K
p30et
31 Jul 23
180 Life Sciences Corp. Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress Appetite
8:00am
8-K
lbcdbqol gyj
10 Jul 23
Departure of Directors or Certain Officers
8:30am
8-K
sh599pe5bw 3x4
28 Apr 23
Departure of Directors or Certain Officers
5:24pm
8-K
9a1hj7qtwsfg
26 Apr 23
Other Events
8:00am
8-K
vvfwvvxo
10 Apr 23
180 Life Sciences Corp. Announces $3 Million Registered Direct Offering and Concurrent Private Placement
4:30pm
8-K
w8nn8k j54uaqrh
23 Feb 23
180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren’s Disease Treatment and Application
8:32am
8-K
rmmdm1
22 Feb 23
Regulation FD Disclosure
4:32pm
8-K
xzr z2kqfzjsga
16 Feb 23
Regulation FD Disclosure
2:50pm